AdipoRon Attenuates Inflammation and Impairment of Cardiac Function Associated With Cardiopulmonary Bypass–Induced Systemic Inflammatory Response Syndrome

Activation of AMPK alleviates cardiopulmonary bypass induced cardiac injury via ameliorating acute cardiac glucose metabolic disorder

(2019) Zhifa Wang et al.   Cardiovascular Therapeutics

Targeting of cell-free DNA by DNase I diminishes endothelial dysfunction and inflammation in a rat model of cardiopulmonary bypass

(2019) Carolyn Weber et al.   Scientific Reports

AdipoRon, an adiponectin receptor agonist, attenuates cardiac remodeling induced by pressure overload

(2018) Ning Zhang et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Metformin attenuated endotoxin-induced acute myocarditis via activating AMPK

(2017) Gang Liu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Cardioprotective effect of metformin in lipopolysaccharide-induced sepsis via suppression of toll-like receptor 4 (TLR4) in heart

(2016) Haleh Vaez et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Modulation of Immunologic Response by Preventive Everolimus Application in a Rat CPB Model

(2016) Antonio Pinto et al.   INFLAMMATION

Selenium Pretreatment for Mitigation of Ischemia/Reperfusion Injury in Cardiovascular Surgery: Influence on Acute Organ Damage and Inflammatory Response

(2016) Holger Steinbrenner et al.   INFLAMMATION

Metformin protects against infection-induced myocardial dysfunction

(2016) Theodora Tzanavari et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings

(2015) Yanqing Zhang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

A Lactate-Induced Response to Hypoxia

(2015) Dong Chul Lee et al.   CELL

Adiponectin protects against Toll-like receptor 4-mediated cardiac inflammation and injury

(2013) Alexander Jenke et al.   CARDIOVASCULAR RESEARCH

Adiponectin Receptor as a Key Player in Healthy Longevity and Obesity-Related Diseases

(2013) Toshimasa Yamauchi et al.   Cell Metabolism

AICAR-dependent AMPK activation improves scar formation in the aged heart in a murine model of reperfused myocardial infarction

(2013) Katarzyna A. Cieslik et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity

(2013) Miki Okada-Iwabu et al.   NATURE

Ronning After the Adiponectin Receptors

(2013) W. L. Holland et al.   SCIENCE

Adiponectin expression in patients with inflammatory cardiomyopathy indicates favourable outcome and inflammation control

(2011) Peter Bobbert et al.   EUROPEAN HEART JOURNAL

A small molecule AMPK activator protects the heart against ischemia–reperfusion injury

(2011) Agnes S. Kim et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

AMP-Activated Protein Kinase Activation during Cardioplegia-Induced Hypoxia/Reoxygenation Injury Attenuates Cardiomyocytic Apoptosis via Reduction of Endoplasmic Reticulum Stress

(2011) Chi-Hsiao Yeh et al.   MEDIATORS OF INFLAMMATION

Adiponectin receptor binding proteins - recent advances in elucidating adiponectin signalling pathways

(2010) Christa Buechler et al.   FEBS LETTERS

The NF- B Family of Transcription Factors and Its Regulation

(2009) A. Oeckinghaus et al.   Cold Spring Harbor Perspectives in Biology